Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/08/1995 | EP0680316A1 Novel parasitic helminth proteins |
11/08/1995 | EP0615439B1 Slow-release ibuprofen-containing medicament and its use |
11/08/1995 | EP0572486B1 Delayed release oral dosage forms for treatment of intestinal disorders |
11/08/1995 | EP0539448B1 Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
11/08/1995 | EP0502143B1 Composition for treating ocular pain |
11/08/1995 | EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
11/08/1995 | EP0423240B1 Modulation of virus-host cell interactions using cyclic oligosaccharides |
11/08/1995 | CN1111454A Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
11/08/1995 | CN1111445A Pharmaceutical emulsions containing bioactive steroids |
11/08/1995 | CN1111247A Protein kinase C inhibitors |
11/08/1995 | CN1111246A Novel cephalopsporin antibiotics and processes for the preparation thereof |
11/08/1995 | CN1111245A Galanthamine derivatives, a process for their preparation and their use as medicaments |
11/08/1995 | CN1111241A Derivative of 2-imidazolin-5-one fungicide |
11/08/1995 | CN1111239A Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkycarboxylates and intermediates |
11/08/1995 | CN1111238A Amino substituted benzosulfonylurea and-thiorea, preparation and pharmaceutical use of same |
11/08/1995 | CN1111234A Salts of pyromellitic acid, a process for their preparation and their use |
11/08/1995 | CN1111154A (Tuofayixisheng) preparation for treatment of alopecia and making method thereof |
11/08/1995 | CN1111130A Stable lyophilized thiotepa composition |
11/08/1995 | CN1111129A Quick-acting skin-changing cream |
11/08/1995 | CN1111128A Topical anti-inflammatory compositions containing piroxican |
11/08/1995 | CN1111127A Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof |
11/08/1995 | CN1111126A Immediate release tablet cores of insoluble drugs having sustained release coating |
11/08/1995 | CN1111125A Liposome solutions |
11/07/1995 | US5464872 Sleep disorders |
11/07/1995 | US5464871 Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents |
11/07/1995 | US5464870 Methods of inhibiting development of leukoplakia with fenretinide |
11/07/1995 | US5464869 Use of dimercaptan acids, salts and metabolites thereof as antiretroviral treatments |
11/07/1995 | US5464868 Prostaglandin E1 derivatives for transdermal administration and methods of treatment therewith |
11/07/1995 | US5464866 Substituted hydrindanes for the treatment of angiogenesis-dependent diseases |
11/07/1995 | US5464864 3-Methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole, salt, solvate or hydrate; 5-hydroxytryptamine; treatment of migraine or headache |
11/07/1995 | US5464863 Anticholesterol agents |
11/07/1995 | US5464862 Method for inhibiting bone loss using centchroman derivatives |
11/07/1995 | US5464861 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties |
11/07/1995 | US5464859 Benzospiroalkene derivatives |
11/07/1995 | US5464858 Hypotensive |
11/07/1995 | US5464857 Smooth muscle relaxants and removal of nitrogen oxides |
11/07/1995 | US5464856 Arylmethylenyl derivatives of imidazolidinones useful as antiinflammatory agents |
11/07/1995 | US5464854 Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S. |
11/07/1995 | US5464849 N-hydroxyurea derivatives as antiallergy and antiinflammatory agents |
11/07/1995 | US5464848 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
11/07/1995 | US5464847 Moduators of corticotropin releasing factor |
11/07/1995 | US5464845 Methods for lowering serum cholesterol |
11/07/1995 | US5464844 [3H,7H]thiazole[3,4-a]pyridines having antiasthmatic and antiinflammatory activities on the respiratory tract |
11/07/1995 | US5464841 Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
11/07/1995 | US5464840 Tricyclic derivatives, compositions and methods of use |
11/07/1995 | US5464838 Aminocarboxylic acid derivatives having antiallergic/antiasthmatic effect and a process for their preparation |
11/07/1995 | US5464837 Method for controlling fish parasites using triazine dione derivatives |
11/07/1995 | US5464835 Antiinflammatory agents |
11/07/1995 | US5464834 N-substituted N'-heterobicyclic piperazines having pharmaceutical activity |
11/07/1995 | US5464829 Cephalosporin derivatives |
11/07/1995 | US5464828 Antiacids or antipepsins for antiulcer agents |
11/07/1995 | US5464827 Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
11/07/1995 | US5464826 Antitumor, anticarcinogenic agents, treatment of herpes |
11/07/1995 | US5464819 Physiologically active peptide having immunoregulatory activities |
11/07/1995 | US5464815 Extending plasma half-life of selectin by coadministering with compound which inhibits binding of selectin to low affinity heparin-like site on surface of cells of organ perfused with blood; assaying sensitivity; pharmaceutical composition |
11/07/1995 | US5464796 7-isoindolinyl-quinolone-carboxylic acid derivatives |
11/07/1995 | US5464788 Tocolytic oxytocin receptor antagonists |
11/07/1995 | US5464781 Amino naphthyridine compounds as anti-rhoumatic agents |
11/07/1995 | US5464650 Intravascular stent and method |
11/07/1995 | US5464634 Red blood cell surrogate |
11/07/1995 | US5464630 Liposomes that provide thymic dependent help to weak vaccine antigens |
11/07/1995 | US5464628 Drug delivery through skins |
11/07/1995 | US5464617 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics |
11/07/1995 | US5464616 6β-substituted penicillanic acids as beta-lactamase inhibitors |
11/07/1995 | US5464610 Method for treating onychomycosis |
11/07/1995 | US5464609 Use of ketorolac for treatment of oral diseases and conditions |
11/07/1995 | CA2148768A1 Analgesic method and composition |
11/07/1995 | CA2147918A1 Percutaneous absorption preparation |
11/07/1995 | CA2020590C Solid pharmaceutical composition containing a core and an outer layer |
11/07/1995 | CA2016470C Pharmaceutical preparation and method of treatment for liver dysfunction |
11/07/1995 | CA2012470C Method for silicon reduction with dimercaptosuccinic acid (dmsa) |
11/07/1995 | CA2012155C Platinum complexes and antitumor agents containing them as an active ingredient |
11/07/1995 | CA1337529C 16-dehydro-vitamin d -derivatives |
11/07/1995 | CA1337527C Forskolin derivatives |
11/07/1995 | CA1337526C Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
11/07/1995 | CA1337523C Pyridonecarboxylic acids and antibacterial agents |
11/07/1995 | CA1337517C Use of dextrin derivatives for the treatment of acidic conditions |
11/06/1995 | EP0687260A4 Process for the preparation of 9-desoxotaxanes |
11/06/1995 | CA2148666A1 Substituted bicyclic heteroaroylguanidines, a process for their preparation, their use as a medicament or a diagnostic agent, and a medicament containing them |
11/06/1995 | CA2148302A1 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
11/05/1995 | CA2122851A1 A cardiotropic formulation |
11/04/1995 | CA2148412A1 1-¬styryl|- and 1-¬2'-(heteroaryl) -ethenyl| -isoquinoline derivatives, a process for preparing them as well as medicaments containing them and the use of them |
11/04/1995 | CA2148324A1 Pyrrolopyrimidine derivatives having pharmacological activity |
11/03/1995 | CA2148312A1 Modified oligonucleotides, their preparation and their use |
11/02/1995 | WO1995029257A2 Apolipoprotein e polymorphism and treatment of alzheimer's disease |
11/02/1995 | WO1995029186A1 Compositions and methods for cell transformation |
11/02/1995 | WO1995029181A1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials |
11/02/1995 | WO1995029180A1 Porphocyanine and cnc-expanded porphyrins |
11/02/1995 | WO1995029178A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof |
11/02/1995 | WO1995029177A1 Tricyclic derivatives as 5ht2c and 5ht2b antagonists |
11/02/1995 | WO1995029176A1 Substituted 1,3-oxathiolanes with antiviral properties |
11/02/1995 | WO1995029173A1 Naphthalene derivatives, method of preparation and use |
11/02/1995 | WO1995029172A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
11/02/1995 | WO1995029165A2 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors |
11/02/1995 | WO1995029164A1 Novel sulfur-containing amino acid derivative |
11/02/1995 | WO1995029159A1 SUBSTITUTED SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
11/02/1995 | WO1995029152A1 Benzamide derivatives as vasopressin antagonists |
11/02/1995 | WO1995029151A1 Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides |
11/02/1995 | WO1995029148A1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
11/02/1995 | WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft |